1. Home
  2. UP vs AVDL Comparison

UP vs AVDL Comparison

Compare UP & AVDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Wheels Up Experience Inc.

UP

Wheels Up Experience Inc.

HOLD

Current Price

$0.62

Market Cap

1.4B

ML Signal

HOLD

Logo Avadel Pharmaceuticals plc

AVDL

Avadel Pharmaceuticals plc

HOLD

Current Price

$21.57

Market Cap

2.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UP
AVDL
Founded
2013
2015
Country
United States
Ireland
Employees
N/A
N/A
Industry
Aerospace
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
2.1B
IPO Year
N/A
1996

Fundamental Metrics

Financial Performance
Metric
UP
AVDL
Price
$0.62
$21.57
Analyst Decision
Buy
Analyst Count
0
9
Target Price
N/A
$18.38
AVG Volume (30 Days)
3.3M
1.6M
Earning Date
11-05-2025
11-04-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$757,468,000.00
$248,517,000.00
Revenue This Year
$174.46
$65.47
Revenue Next Year
N/A
$30.88
P/E Ratio
N/A
N/A
Revenue Growth
N/A
79.88
52 Week Low
$0.59
$6.38
52 Week High
$3.50
$23.57

Technical Indicators

Market Signals
Indicator
UP
AVDL
Relative Strength Index (RSI) 38.16 60.27
Support Level $0.61 $21.36
Resistance Level $0.78 $21.67
Average True Range (ATR) 0.09 0.12
MACD 0.02 -0.10
Stochastic Oscillator 6.02 70.89

Price Performance

Historical Comparison
UP
AVDL

About UP Wheels Up Experience Inc.

Wheels Up Experience Inc is a provider of on-demand private aviation in the United States. It is pioneering data and technology-driven solutions that connect consumers to safety-vetted and verified private aircraft. It connects private flyers to aircraft, and one another, through an open platform that enables life's most important experiences. Its offering is delivered through a mix of programmatic and charter options that strategically utilize its owned and leased aircraft fleet and an "asset-light" charter model to deliver a greater range of global travel alternatives. The company operates in a single operating and reportable segment, private aviation services. Geographically the company generates the majority of its revenue from the United States.

About AVDL Avadel Pharmaceuticals plc

Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. The group focused on transforming medicines to transform lives. It provides solutions to the development of medications that address the challenges patients face with current treatment options. The company is engaged in the development of differentiated drug products for administration in various forms such as capsules, tablets, injectables etc. Its commercialized product LUMRYZ is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or EDS in adults with narcolepsy. It operates in one segment, the development and commercialization of pharmaceutical products, including controlled-release therapeutic products based on its proprietary polymer-based technology.

Share on Social Networks: